Marjolein De Bruin-Weller - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Marjolein De Bruin-Weller

Showing results (1-10 of 80) with videos related to

Pageof 8

Sort By:

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2019

Management of dupilumab-associated conjunctivitis in atopic dermatitisNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.

Chemical Immunology and Allergy|March 22, 2012

Bone mineral density in patients with atopic dermatitisInge Haeck, Sara van Velsen, Marjolein de Bruin-Weller, et al.

Dermatitis : Contact, Atopic, Occupational, Drug|August 30, 2007

Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patientsDirk Jan Hijnen, Edward Knol, Carla Bruijnzeel-Koomen, et al.

The Journal of Allergy and Clinical Immunology|February 15, 2023

Biomarkers in atopic dermatitisDaphne Bakker, Marjolein de Bruin-Weller, Julia Drylewicz, et al.

Journal of Clinical Medicine|August 5, 2015

Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional StudyHarmieke van Os-Medendorp, Simone Appelman-Noordermeer, Carla Bruijnzeel-Koomen, et al.

JMIR Research Protocols|May 23, 2015

Usage and users of online self-management programs for adult patients with atopic dermatitis and food allergy: an explorative studyHarmieke van Os-Medendorp, Ilse van Leent-de Wit, Marjolein de Bruin-Weller, et al.

Journal of Clinical Medicine|August 5, 2015

New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2026

European consensus recommendations for nummular eczema: A modified Delphi studyMette Deleuran, Kilian Eyerich, Marjolein de Bruin-Weller, et al.

Dermatology and Therapy|November 22, 2021

Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 WeeksAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.

Journal of the American Academy of Dermatology|September 10, 2014

Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severityJanneke Landheer, Marjolein de Bruin-Weller, Chantal Boonacker, et al.

Pageof 8

Search research articles

Showing results (1-10 of 80) with videos related to

Sort By:

Pageof 8

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 16, 2019

Management of dupilumab-associated conjunctivitis in atopic dermatitisNora Aszodi, Stephan Thurau, Marlene Seegräber, et al.

Chemical Immunology and Allergy|March 22, 2012

Bone mineral density in patients with atopic dermatitisInge Haeck, Sara van Velsen, Marjolein de Bruin-Weller, et al.

Dermatitis : Contact, Atopic, Occupational, Drug|August 30, 2007

Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patientsDirk Jan Hijnen, Edward Knol, Carla Bruijnzeel-Koomen, et al.

The Journal of Allergy and Clinical Immunology|February 15, 2023

Biomarkers in atopic dermatitisDaphne Bakker, Marjolein de Bruin-Weller, Julia Drylewicz, et al.

Journal of Clinical Medicine|August 5, 2015

Sick Leave and Factors Influencing Sick Leave in Adult Patients with Atopic Dermatitis: A Cross-Sectional StudyHarmieke van Os-Medendorp, Simone Appelman-Noordermeer, Carla Bruijnzeel-Koomen, et al.

JMIR Research Protocols|May 23, 2015

Usage and users of online self-management programs for adult patients with atopic dermatitis and food allergy: an explorative studyHarmieke van Os-Medendorp, Ilse van Leent-de Wit, Marjolein de Bruin-Weller, et al.

Journal of Clinical Medicine|August 5, 2015

New Developments in Biomarkers for Atopic DermatitisJudith L Thijs, Wouter van Seggelen, Carla Bruijnzeel-Koomen, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2026

European consensus recommendations for nummular eczema: A modified Delphi studyMette Deleuran, Kilian Eyerich, Marjolein de Bruin-Weller, et al.

Dermatology and Therapy|November 22, 2021

Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 WeeksAndrew Blauvelt, Marjolein de Bruin-Weller, Eric L Simpson, et al.

Journal of the American Academy of Dermatology|September 10, 2014

Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severityJanneke Landheer, Marjolein de Bruin-Weller, Chantal Boonacker, et al.

Pageof 8